Noxilizer Licenses Sterilization Technology to Eniware for Developing World and Related Markets

Eniware to develop Noxilizer sterilization technology for developing world, first responder and military applications.

(Baltimore, MD and Washington, DC – February 27, 2012) Noxilizer, Inc. and Eniware LLC announced an agreement today to develop portable, power-independent medical device sterilization units for the developing world, disaster response, and military markets. Noxilizer is licensing its proprietary nitrogen dioxide sterilization technology. Eniware will be responsible for the development, manufacturing, and commercialization of this product line.

Infection and disease transmission in clinics and hospitals afflict millions in the developing world. Sterile medical instruments can mean the difference between life and death. Reported healthcare-related infection (HRI) rates in developing countries range from 15% to 40% or more. This problem only grows as access to healthcare grows, particularly with the expansion of simple, basic surgery in under-resourced settings. Potentially lifesaving procedures tragically cripple or kill millions of men, women, and children due to lack of affordable, effective sterilization of medical equipment. With the introduction of power-independent sterilization units, there is an opportunity to reduce the incidence of infection and save lives anywhere, at any time.

“This licensing agreement further validates Noxilizer’s technology and its importance in solving a variety of sterilization needs – including the most challenging of environments. Our partnership with Eniware will enable sterilization solutions that improve the quality of medical care and reduce the incidence of infection for people who do not have immediate access to a fully-equipped hospital,” says Lawrence Bruder, President & CEO of Noxilizer, Inc.

“As a physician, I know how important the sterilization issue is in any medical setting, and especially in the developing world, disaster areas and on the battlefield. The opportunity to use my medical and business experience to solve this problem is the opportunity of a lifetime,” states James Bernstein, MD, President & CEO of Eniware LLC.

Eniware is in the process of finalizing funding for the development effort. Potential customers include: global health organizations, governments of developing countries, global first responder organizations, and militaries.

About Noxilizer, Inc.:

Noxilizer has a unique and superior NO2-based sterilization technology that is revolutionizing two major sterilization markets — medical device/pharmaceutical/biotechnology manufacturing and hospitals. In the manufacturing market, Noxilizer provides sterilization services for next generation medical devices and drug/device combination products. Noxilizer also sells the RTS 360 NO2 Sterilization System to companies that sterilize their own products. In hospitals, Noxilizer is developing a system especially for the sensitive, high-tech equipment used in minimally-invasive surgical procedures. The company was founded in 2004 and is privately held. Noxilizer is located at the University of Maryland Baltimore County Technology Center in Baltimore, MD.

About Eniware LLC:

Eniware LLC is a privately-held company based in Washington, DC. Formed in 2011, Eniware is committed to bringing critical sterilization technology to the developing world, first responders, and militaries.

Media Contacts:.
Maura O. Kahn
Vice President, Business Development & Marketing
Noxilizer, Inc.
O (443) 543-5783
M (202) 744-6337
mokahn@noxilizer.com

Eric Verkerke
Director of Communications & Product Development
Eniware, LLC
(434) 260-1809
Eric.Verkerke@EniwareSterile.com